To assess the impact of age on SARS-CoV-2–cross-reactive T cell immunity, we examined SARS-CoV-2 spike–specific CD4+ T cell responses in 568 unexposed individuals and 174 COVID-19 convalescents (Fig. 2A and table S1). This evidence concerns the gene CD4 and COVID-19.